Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Peter Yeow

About me

I am a DPhil student funded by A*STAR Singapore under the National Science Scholarship. I am also affiliated with St Cross College. My DPhil project has led to the identification of a novel synthetic lethal gene interaction in breast cancer, providing a strong rationale for the targeting of a key kinase involved in centrosome biology and mitosis. Prior to this, I was in the p53 Lab Singapore investigating peptides that could reactivate the frequently mutated p53 tumour suppressor protein, supervised by Dr Walter Goh and Sir David Lane.  

Research interests : Therapeutics, cancer genetics, breast cancer, mitosis, centrosomes

Yeow, Z.Y., Lambrus, B.G., Marlow, R. et al. Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. Nature 585, 447–452 (2020).

Zheng, X. T., Goh, W. L., Yeow, P., Lane, D. P., Ghadessy, F. J., & Tan, Y. N. (2019). Ultrasensitive dynamic light scattering based nanobiosensor for rapid anticancer drug screening. Sensors and Actuators B: Chemical, 279, 79-86. doi: